Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Nashville › NPI 1396882205
Hospital

Vanderbilt University Medical Center

Vanderbilt University Medical Center was paid $137.59M by Medicaid between Jan 2018 and Dec 2024, across 487 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 29% of everything it billed.

33Billing provider infoVANDERBILT UNIVERSITY MEDICAL CENTER
NASHVILLE, TN 37232
33aNPI1396882205assigned 01/31/2007
28Total paid$137.59M
24GClaims2,376,792
24DCodes billed487
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in Tennessee

Rank by total paid#1 of 11
Median peer was paid$159K
This provider vs. median863×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SIMMONS, ANGELA controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018285,452$17.87M
2019334,184$19.33M
2020292,687$16.14M
2021344,630$19.73M
2022375,382$20.70M
2023396,356$22.44M
2024incomplete348,101$21.39M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0463 Hospital outpatient clinic visit for assessment and management of a patient 29% 529,039 475,605 $39.69M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 88,578 86,354 $13.98M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.3% 33,100 28,967 $12.85M
42820 Tonsillectomy and adenoidectomy; younger than age 12 9.3% 4,255 4,093 $12.78M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.4% 23,741 22,304 $6.12M
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 3.2% 3,775 3,512 $4.35M
J0475 Injection, baclofen, 10 mg 2.7% 5,178 3,641 $3.75M
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.3% 23,678 22,967 $1.76M
G0378 Hospital observation service, per hour 1.2% 3,500 3,008 $1.61M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.2% 2,108 2,003 $1.59M
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 1.1% 5,196 4,800 $1.55M
70551 Magnetic resonance imaging, brain; without contrast material 1.1% 3,272 3,114 $1.49M
475 more codes
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.0% 3,780 $1.38M
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 2,493 $1.26M
95782 <1% 1,666 $1.23M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 2,003 $1.16M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 8,588 $1.13M
41899 Unlisted procedure, dentoalveolar structures <1% 1,306 $1.13M
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 40,242 $976K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 120,220 $822K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 1,082 $816K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 696 $695K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 4,068 $690K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 8,453 $674K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 5,697 $614K
80053 Comprehensive metabolic panel <1% 60,687 $612K
A0425 Ground mileage, per statute mile <1% 4,799 $611K
41010 <1% 471 $529K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 5,758 $495K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 26,562 $474K
J2323 Injection, natalizumab, 1 mg <1% 144 $471K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 24,768 $470K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 26,537 $468K
90677 <1% 4,972 $463K
93325 <1% 11,784 $458K
92587 <1% 3,057 $438K
94010 <1% 7,740 $420K
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 7,013 $357K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 39,326 $353K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 22,307 $349K
80048 Basic metabolic panel (calcium, ionized) <1% 42,664 $346K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 7,778 $337K
84443 Thyroid stimulating hormone (TSH) <1% 25,707 $332K
54161 <1% 362 $322K
90670 <1% 5,322 $318K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,030 $306K
96375 Therapeutic injection; each additional sequential IV push <1% 3,426 $305K
36415 Collection of venous blood by venipuncture <1% 85,378 $302K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,450 $292K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 27,275 $292K
92579 <1% 5,911 $273K
93320 <1% 5,164 $262K
71046 Radiologic examination, chest; 2 views <1% 6,472 $261K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 3,820 $257K
70450 Computed tomography, head or brain; without contrast material <1% 783 $248K
92567 <1% 18,232 $247K
J2704 Injection, propofol, 10 mg <1% 23,104 $240K
74018 <1% 5,880 $240K
76819 Fetal biophysical profile; without non-stress testing <1% 3,508 $237K
86900 <1% 10,766 $230K
95816 <1% 1,651 $228K
J3490 Unclassified drugs <1% 17,970 $227K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,875 $209K
80061 Lipid panel <1% 14,236 $205K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 5,967 $196K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 24,763 $195K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 2,591 $193K
76770 <1% 2,048 $189K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 27,087 $178K
83655 <1% 13,447 $174K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,216 $172K
83036 Hemoglobin; glycosylated (A1C) <1% 30,045 $169K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 1,806 $165K
92551 <1% 12,341 $158K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 10,286 $143K
84439 <1% 16,117 $138K
87536 <1% 3,154 $132K
J1170 Injection, hydromorphone, up to 4 mg <1% 11,184 $129K
86780 <1% 12,761 $128K
81416 <1% 13 $126K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 1,392 $124K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,599 $122K
95117 <1% 4,345 $121K
59025 Fetal non-stress test <1% 1,696 $117K
90472 Immunization administration, each additional vaccine (list separately) <1% 19,205 $116K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 18,692 $113K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 1,444 $109K
96161 <1% 10,483 $107K
96127 <1% 14,574 $101K
42830 <1% 56 $99K
86850 <1% 10,438 $95K
82728 <1% 8,877 $95K
72082 <1% 3,554 $95K
81025 <1% 15,640 $94K
80305 <1% 10,812 $91K
85027 <1% 24,769 $88K
83516 <1% 3,233 $86K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 5,716 $82K
93296 <1% 7,166 $80K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,014 $78K
83735 <1% 12,567 $78K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 13 $77K
83880 <1% 2,630 $77K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 1,209 $77K
76775 <1% 1,898 $76K
90837 Psychotherapy session, about an hour <1% 2,372 $76K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,942 $76K
62370 <1% 1,387 $75K
J0690 Injection, cefazolin sodium, 500 mg <1% 3,481 $75K
87081 <1% 11,469 $72K
90686 <1% 14,501 $72K
82570 <1% 7,998 $72K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 153 $71K
90847 Family psychotherapy with the patient present, 50 minutes <1% 1,104 $70K
87086 Culture, bacterial; quantitative colony count, urine <1% 19,031 $68K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,855 $68K
86360 <1% 3,072 $68K
86140 <1% 14,019 $66K
49452 <1% 94 $64K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,347 $64K
87631 <1% 876 $63K
80076 <1% 9,884 $63K
90834 Psychotherapy session, about 45 minutes <1% 2,154 $63K
72170 <1% 1,558 $62K
A0427 Emergency ambulance ride, advanced life support <1% 151 $62K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,187 $61K
G0008 Administration of influenza virus vaccine <1% 4,953 $59K
86359 <1% 3,203 $59K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 76 $59K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 10,343 $59K
82784 <1% 7,969 $58K
95715 <1% 151 $55K
87653 <1% 2,768 $54K
80197 <1% 11,277 $54K
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) <1% 1,371 $53K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 220 $51K
86901 <1% 10,673 $49K
72141 <1% 137 $48K
36591 <1% 1,797 $47K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 898 $46K
83970 <1% 2,088 $46K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 11,258 $46K
92582 <1% 700 $45K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 9,209 $43K
85651 <1% 14,488 $43K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 3,274 $43K
C1769 Guide wire <1% 1,213 $40K
81002 <1% 12,517 $39K
90791 Psychiatric diagnostic evaluation <1% 420 $39K
82977 <1% 8,724 $39K
81415 <1% 15 $38K
76830 Ultrasound, transvaginal <1% 554 $38K
J7999 Compounded drug, not otherwise classified <1% 2,340 $37K
87799 <1% 1,203 $37K
97803 <1% 998 $36K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 759 $36K
90715 <1% 1,275 $36K
85610 <1% 6,813 $34K
0001A <1% 1,036 $33K
76825 <1% 148 $33K
86803 <1% 6,286 $33K
85018 <1% 15,302 $33K
0002A <1% 957 $33K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 108 $33K
90656 <1% 3,018 $33K
14040 <1% 85 $33K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 70 $31K
95819 <1% 227 $30K
85045 <1% 11,727 $30K
71045 Radiologic examination, chest; single view <1% 415 $30K
84100 <1% 10,629 $30K
81001 <1% 16,943 $30K
96415 <1% 298 $30K
86364 <1% 2,712 $29K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 268 $28K
0071A <1% 700 $28K
82248 <1% 3,987 $28K
82950 <1% 3,423 $27K
96900 <1% 1,151 $27K
86832 <1% 323 $26K
A9585 Injection, gadobutrol, 0.1 ml <1% 1,285 $26K
87340 <1% 9,823 $26K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 1,506 $26K
95700 <1% 179 $26K
95991 <1% 516 $25K
76820 <1% 1,239 $24K
92556 <1% 535 $24K
0072A <1% 586 $24K
86833 <1% 289 $23K
92060 <1% 3,975 $23K
92552 <1% 814 $23K
82962 <1% 2,093 $22K
83550 <1% 2,926 $22K
72146 <1% 107 $21K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 627 $21K
72125 Computed tomography, cervical spine; without contrast material <1% 39 $20K
90620 <1% 546 $19K
86258 <1% 1,956 $19K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 173 $19K
36416 <1% 11,862 $19K
90480 <1% 756 $18K
83690 <1% 2,094 $18K
92555 <1% 1,224 $18K
83021 <1% 2,743 $18K
83540 <1% 3,330 $18K
84702 <1% 1,388 $17K
99173 <1% 12,013 $17K
83605 <1% 1,136 $17K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 198 $17K
93304 <1% 75 $16K
84156 <1% 5,602 $16K
85730 <1% 1,982 $16K
82565 <1% 2,155 $16K
92611 <1% 240 $15K
87070 <1% 1,404 $15K
73590 <1% 256 $15K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 106 $14K
82261 <1% 14 $14K
97802 <1% 268 $14K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 39 $14K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,260 $14K
74230 <1% 223 $13K
73552 <1% 262 $13K
47000 <1% 13 $13K
93308 <1% 140 $13K
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 422 $12K
93975 <1% 67 $12K
76981 <1% 196 $12K
36430 <1% 83 $11K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 814 $11K
95076 <1% 37 $11K
81229 <1% 43 $11K
96376 <1% 324 $10K
86003 <1% 249 $10K
72081 <1% 746 $10K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 168 $9K
54360 <1% 12 $9K
93321 <1% 327 $9K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 374 $9K
73560 <1% 440 $9K
90461 <1% 877 $8K
93226 <1% 116 $8K
82803 <1% 417 $8K
77072 <1% 545 $8K
73610 <1% 138 $8K
88342 <1% 104 $8K
82610 <1% 1,555 $8K
70480 <1% 54 $8K
86762 <1% 5,174 $8K
82550 <1% 898 $8K
87497 <1% 448 $7K
87077 <1% 922 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 288 $7K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 388 $7K
43762 <1% 37 $7K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 204 $7K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 240 $6K
93270 <1% 173 $6K
86255 <1% 510 $6K
84460 <1% 1,225 $6K
90792 Psychiatric diagnostic evaluation with medical services <1% 79 $6K
82139 <1% 983 $6K
97161 <1% 79 $6K
84484 <1% 544 $5K
97162 <1% 72 $5K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 260 $5K
31622 <1% 26 $5K
84450 <1% 1,159 $5K
88720 <1% 1,415 $5K
96910 <1% 527 $5K
90723 <1% 7,124 $5K
84144 <1% 593 $5K
86038 <1% 1,155 $5K
82105 <1% 1,206 $5K
82607 <1% 464 $5K
73090 <1% 234 $5K
86706 <1% 990 $4K
96112 <1% 45 $4K
83520 <1% 280 $4K
C1889 Implantable/insertable device, not otherwise classified <1% 2,067 $4K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 15 $4K
90846 Family psychotherapy without the patient present, 50 minutes <1% 56 $4K
90661 <1% 641 $4K
90380 <1% 121 $4K
92553 <1% 21 $4K
87186 <1% 425 $4K
87481 <1% 142 $4K
J1596 Injection, glycopyrrolate, 0.1 mg <1% 799 $4K
90688 <1% 373 $3K
93356 <1% 163 $3K
84520 <1% 712 $3K
82042 <1% 732 $3K
J1644 Injection, heparin sodium, per 1000 units <1% 711 $3K
83615 <1% 841 $3K
86704 <1% 868 $3K
96160 <1% 378 $3K
52287 <1% 14 $3K
76827 <1% 148 $3K
81407 <1% 30 $3K
74019 <1% 62 $3K
90832 Psychotherapy session, about 30 minutes <1% 61 $3K
96380 <1% 121 $3K
92557 <1% 54 $3K
80195 <1% 256 $3K
73070 <1% 85 $3K
86902 <1% 50 $3K
92083 <1% 482 $3K
96361 Intravenous infusion, hydration; each additional hour <1% 72 $2K
0124A <1% 71 $2K
G0009 Administration of pneumococcal vaccine <1% 135 $2K
76813 <1% 79 $2K
84403 <1% 110 $2K
81408 <1% 15 $2K
99195 <1% 51 $2K
73630 <1% 138 $2K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 63 $2K
77073 <1% 62 $2K
82043 <1% 164 $2K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 132 $2K
82330 <1% 273 $2K
73100 <1% 145 $2K
82040 <1% 1,004 $2K
90685 <1% 164 $2K
Q3014 Telehealth originating site facility fee <1% 749 $2K
J1171 Injection, hydromorphone, 0.1 mg <1% 273 $2K
90648 <1% 10,124 $2K
86376 <1% 414 $2K
76857 <1% 24 $2K
82104 <1% 387 $2K
83993 <1% 111 $2K
90678 <1% 18 $2K
84305 <1% 98 $2K
82390 <1% 576 $2K
90716 <1% 2,543 $2K
87205 <1% 290 $2K
88313 <1% 41 $2K
86481 <1% 24 $2K
92133 <1% 288 $2K
96138 <1% 64 $2K
76885 <1% 32 $2K
96450 <1% 16 $2K
0081A <1% 40 $1K
81513 <1% 13 $1K
96136 <1% 151 $1K
96111 <1% 14 $1K
96113 <1% 17 $1K
94729 <1% 72 $1K
87522 Neg quan hep c or qual rna <1% 266 $1K
64615 <1% 15 $1K
87102 <1% 42 $1K
77080 <1% 34 $1K
97763 <1% 15 $1K
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 407 $1K
92526 <1% 15 $1K
93017 <1% 15 $1K
62369 <1% 27 $1K
0054A <1% 27 $1K
93567 <1% 13 $998.24
84402 <1% 33 $963.06
94726 <1% 31 $948.19
76376 <1% 14 $940.66
92002 <1% 14 $925.56
76942 <1% 32 $867.62
86800 <1% 47 $864.10
90707 <1% 2,534 $850.70
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 31 $816.17
96116 <1% 15 $814.66
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 58 $809.10
90381 <1% 192 $795.87
86015 <1% 366 $766.23
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 13 $762.24
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination <1% 13 $758.20
90633 <1% 2,842 $733.97
81321 <1% 15 $720.00
86480 <1% 13 $713.85
90474 <1% 579 $671.61
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 14 $667.92
81302 <1% 15 $633.44
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 8,337 $600.20
73080 <1% 29 $582.22
J2270 Injection, morphine sulfate, up to 10 mg <1% 26 $575.85
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 15 $573.50
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 4,330 $572.76
87040 <1% 32 $560.79
0082A <1% 14 $560.00
87147 <1% 86 $557.32
75565 <1% 15 $527.80
84270 <1% 33 $523.85
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 6,473 $501.78
0004A <1% 13 $480.80
0154A <1% 12 $480.00
90651 <1% 1,037 $479.40
62367 <1% 18 $462.91
86709 <1% 176 $446.40
84550 <1% 181 $444.55
40806 <1% 81 $438.15
81243 <1% 21 $416.00
87015 <1% 119 $388.70
86696 <1% 291 $379.20
82746 <1% 42 $376.70
96381 <1% 87 $373.50
73562 <1% 36 $363.94
90734 <1% 372 $363.83
94664 <1% 27 $358.18
86160 <1% 110 $353.73
86708 <1% 189 $353.08
83001 <1% 15 $319.63
85055 <1% 12 $318.69
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 829 $318.01
51798 <1% 84 $309.83
70355 <1% 15 $304.78
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 21 $302.60
90674 <1% 4,330 $292.17
84590 <1% 25 $280.96
J9370 Vincristine sulfate, 1 mg <1% 34 $276.21
85384 <1% 45 $271.23
J7030 Infusion, normal saline solution , 1000 cc <1% 52 $269.23
86695 <1% 291 $259.11
82435 <1% 133 $252.51
82627 <1% 12 $235.85
96130 <1% 96 $227.34
92134 <1% 18 $217.79
77067 Screening mammography, bilateral, including computer-aided detection <1% 12 $209.70
84446 <1% 14 $206.27
99381 <1% 76 $206.00
69210 <1% 41 $196.03
95885 <1% 31 $196.02
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 132 $191.90
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 168 $184.38
J1756 Injection, iron sucrose, 1 mg <1% 25 $180.44
82077 <1% 13 $177.78
87807 <1% 12 $176.30
G0381 Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 12 $169.30
85014 <1% 41 $140.74
87210 <1% 47 $125.84
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 63 $120.84
J0561 Injection, penicillin g benzathine, 100,000 units <1% 15 $104.42
82274 <1% 14 $99.96
82525 <1% 17 $89.98
V5266 Battery for use in hearing device <1% 17 $84.60
85049 <1% 15 $77.20
90700 <1% 150 $73.27
92015 Determination of refractive state <1% 142 $72.80
87088 <1% 15 $72.10
83525 <1% 14 $69.17
85245 <1% 17 $65.22
85246 <1% 17 $65.22
83010 <1% 70 $63.90
92250 <1% 14 $63.63
89051 <1% 13 $59.74
85240 <1% 17 $50.90
82787 <1% 46 $22.44
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 12 $17.60
80354 <1% 818 $12.08
80047 <1% 31 $11.91
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,408 $10.42
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 69 $9.96
91300 <1% 591 $4.69
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 61 $2.82
91307 <1% 286 $2.33
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 30 $0.04
90680 0% 5,890 $0.00
88300 0% 381 $0.00
A9270 Non-covered item or service 0% 528 $0.00
87116 0% 103 $0.00
96131 0% 80 $0.00
90696 0% 110 $0.00
96139 0% 64 $0.00
87206 0% 103 $0.00
88307 0% 13 $0.00
92650 0% 13 $0.00
83498 0% 14 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 15 $0.00
J3430 Injection, phytonadione (vitamin k), per 1 mg 0% 13 $0.00
83789 0% 14 $0.00
80348 0% 4,477 $0.00
92025 0% 26 $0.00
A0100 Non-emergency taxi ride to a medical appointment 0% 106 $0.00
76000 0% 14 $0.00
81479 Unlisted molecular pathology procedure 0% 14 $0.00
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 0% 131 $0.00
96137 0% 95 $0.00
82760 0% 14 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 0% 250 $0.00
80175 0% 25 $0.00
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 0% 12 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 25 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSIMMONS, ANGELA (VP FINANCE-REVENUE AND REIMBURSEMEN)
Same official

Other billing entities under SIMMONS, ANGELA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.